Pharmacology Flashcards
(33 cards)
Pharmacokinetics
study of absorption, distribution, metabolism, and excretion/elimination from the body
(What the body does to the drug)
Pharmacodynamics
study of responsiveness, of receptors to a drug and mechanisms by which these effects occur and impact the body
(What the drug does to the body)
ADME
Absorption - drug movement from site of administration to circulatory system
Distribution - reaching the site of action at a high enough concentration for a sufficent period of time for a response to be produced
Metabolism - reached site of action and produced clinical effect (liver most often) (Oxidation, reduction, hydrolysis, hydration, conjunction)
Elimination - removal of drug from body (most often urine), liver, bile, sweat, lungs, milk, tears, saliva
What can affect distribution?
Hypoalbuminemia
Acidemia
MDR 1
Cellular Signaling
G-protein coupled receptors
cAMP, IP3, DAG
Adrenergic, opioids, vasopressors and insulin
Inotropic receptors - NMDA, GABA A receptors
Chelation
Bind directly to metals in the body and promote elimination
EDTA - binds with calcium in blood to prevent clotting
Receptor Interactions
Agonists - mimic affect of receptor
Antagonists - binds to receptor and blocks the response
Partial agonists - bind to receptor but have partial or incomplete efficacy
Pediatric patients
Distribution may be altered due to increased total body water, decreased fat stores, hypoproteinemia
renal system not fully developed - drug clearance
Geriatric patients
CKD - reduce GFR - decrease drug clearance
Emetics
Apomorphine
Alpha 2 Agonists
Peripheral acting emetics - H2O2
Antiemetics
Phenothiazine Derivatives
Metoclopramide
Serotonin (5HT3) Antagonists
Maropitant - NK1 antagonist
Apomorphine
stimulates dopamine, serotonin, alpha adrenergic, opioid receptors, stimulates CRTZ
Reversed with metoclopramide or naloxone
Alpha 2 Agonists
Xylazine, stimulation of CRTZ
Reversed with atipamazole
Phenothiazine Derivatives
acepromazine, chlorpromazine, prochlorperazine
Block dopamine receptors in CRTZ
Alpha 1 antagonist effect = reduced SVR and vasodilation
Metoclopramide
Prokinetic
dopamine and serotonin antagonist, cholinergic agonist
Gastric emptying, increases lower esophageal sphincter tone
Can interfere with other drugs that work on similar receptors
(DO NOT USE IN INTUSSUSCEPTIONS OR OBSTRUCTIONS)
Serotonin (5HT3) Antagonists
ondansetron and dolasetron
block serotonin receptors in CRTZ
Maropitant
NK 1 antagonist - blocks substance P at vomiting center (bone marrow suppression under 8 weeks old)
Confirmed no obstruction prior to use –> mask decline
Antitussive effect
Gastroprotectant Drugs
Proton Pump Inhibitors
H2 histageneric Antagonists
Sucralfate
Misoprostol
Proton Pump Inhibitors
Omeprazole, pantoprazole, esomeprazole
Inhibits Na/K ATPase pump activity –> controls proton deposition into gastric lumen and HCL secretion
H2 Histageneric Antagonists
“H2 blockers”
Famotidine, ranitidine, cimetidine
Reduce histamine at receptors on gastric parietal cells and reduce stomach acid production
Sucralfate
Sucrose sulfate aluminum complex drug - bind to locally injured GI lining and create a barrier
Separate by 2 hours from food or meds
Misoprostol
Synthetic prostaglandin E1 analogue –> improve gastric blood flow, decrease gastric acid production, increase mucous production and bicarb secretion and promote cell turnover
Used to help prevent NSAID-induced GI injury and ulceration
Antiarrhythmic Drugs
Class 1 - sodium channel blockers
Class 2 - beta blockers
Class 3 - potassium channel blockers
Class 4 - calcium channel blockers
Class 5 - Misc
Class 1 antiarrythmics
Sodium Channel blockers
1A - quinidine, procainamide (ventricular and supraventricular arrythmias)
1B - lidocaine, mexiletine - ventricular arrythmias
1C - flecainide